MOESM1 of Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Additional file 1: Figure S1. MEM-PLGA-PEG NPs transmission electron microscopy and size distribution obtained by dynamic light scattering. Figure S2. MEM thermogravimetric and differential thermal analysis. Figure S3. A) Experimental groups involved on the study, B) In vivo Timeline. Figure S4. Escape latency results of the Morris water maze test on the probe trail of the WT mice

Additional file 1 of Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum

Additional file 1. Supplementary material associated with this article is provided

Additional file 1 of Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort

Additional file 1. Multiple linear regression analyses of the association of clinical, demographic and biomarker variables with macular VD. Including hypertension, diabetes mellitus, dyslipidemia, heart disease, respiratory disease and smoking as adjusting factors. Significance was set up at p < 0.05. Abbreviations: A: amyloid; APOE: apolipoprotein E; CI: confidence interval; VD: vessel density